Search results for: liver

Update on Healthcare Reform in 2014 under the Affordable Care Act

Joseph Flood, MD, & Kam Nola, PharmD, MS | June 1, 2014

The American College of Rheumatology continues to monitor healthcare system changes under the ACA; educate rheumatologists, rheumatology health professionals

Why Farber Disease May Be Misdiagnosed as Juvenile Idiopathic Arthritis

Boris Hugle, MD, MSc, Laura Mueller & Thierry Levade, MD, PhD | June 1, 2014

A case study reveals how late presentation of this rare, autosomal-recessive disorder, which can involve arthritis-like symptoms, can be mistaken for JIA

Rheuminations: Ankylosing Spondylitis Sometimes Defies Detection

Simon M. Helfgott, MD | May 1, 2014

How method of diagnosing, treating this inflammatory back disease characterized by stiffness and the presence of HLA-B27 gene has evolved

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP | April 2, 2014

Information on acetaminophen restrictions; trials for clazakizumab, epratuzumab, romosozumab; and drug safety updates rheumatologists need to know

Therapeutic Value of Colchicine in Osteoarthritis, Cardiovascular Disease Explored at the ACR/ARHP Winter Rheumatology Symposium

Kimberly Retzlaff | April 2, 2014

Drug’s antiinflammatory properties may help alleviate pain in patients with OA, reduce risk of myocardial infarction, but toxicity, drug interactions need to be considered

Methotrexate May Mitigate Inflammatory Bone Disease Note Experts at the ACR/ARHP Winter Rheumatology Symposium

Kimberly Retzlaff | April 2, 2014

By regulating molecules key to osteoclast/osteoblast processes, methotrexate may reduce bone destruction in inflammatory arthritis, osteolysis, especially in combination with adenosine

State-of-the-Art Clinical Symposium Scheduled for April 26–27 in Chicago

Staff | April 2, 2014

ACR’s education and networking seminar to address latest in therapy, research, and scientific advances in rheumatology

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP | March 1, 2014

Information on new approvals and medication safety that rheumatologists need to know

Evolutionary Medicine Provides Insight into the Chronic Inflammatory State Note Rheumatologists at the 2013 ACR/ARHP Annual Meeting

Mary Beth Nierengarten | March 1, 2014

Studies on metabolism, neuroendocrinology, and immunology can broaden understanding of the pathophysiology of chronic inflammatory diseases

2014 State-of-the-Art Clinical Symposium to Be Held April 26–27 in Chicago

Staff | March 1, 2014

ACR’s education and networking seminar to address latest in research, therapy, and scientific advances in rheumatology